Get access

Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study

Authors


  • Competing Interests: Please see supplementary files.

Correspondence: E Daudén. E-mail:estebandauden@medynet.com

No abstract is available for this article.

Ancillary